Group 1 - Wanglaoji and JDB have resumed their public feud, trending on social media with topics like "Wanglaoji has a problem, go to the hospital" and "Wanglaoji is the first to get angry" [1] - The conflict has escalated with both companies making statements regarding trademark disputes, particularly concerning the overseas rights to the Wanglaoji brand [4][10] - JDB claims to have successfully defended its overseas trademark rights in multiple lawsuits, marking a significant step in its international branding strategy [4][8] Group 2 - Wanglaoji's parent company, Baiyunshan, asserts that it holds the legal rights to the Wanglaoji trademark globally, having registered it in over 100 countries [10][11] - Both companies have been engaged in a long-standing trademark dispute, with JDB emphasizing its acquisition of the Wanglaoji brand's overseas rights in the early 2000s [10][14] - The ongoing rivalry has implications for both companies' market performance, with potential impacts on their respective sales and brand positioning [14][16] Group 3 - The herbal tea market remains a viable business opportunity, with significant growth potential in overseas markets despite a slowdown in domestic growth [14][15] - Wanglaoji reported a revenue of 6.499 billion yuan in the first half of 2025, a year-on-year increase of 8.38%, and a net profit of 1.295 billion yuan, up 15.87% [14] - JDB has also been expanding its market presence, with a reported 28.31% market share in the domestic plant beverage category, closely following Wanglaoji's 46.33% [16]
王老吉加多宝“20年缠斗”,鹿死谁手?